Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
7th grade Avg
|
New words:
absorb, accrual, analyst, array, Asia, begun, beneficiary, biodegradable, Biology, Biomedical, breast, broad, cancer, canker, cardiovascular, catastrophic, Celee, Certified, cGMP, challenging, Chinese, chosen, climbing, closure, collaboration, compensatory, comprehensive, COO, counted, cytotoxic, deliverable, desire, detail, detailed, detrimental, diet, differential, discovery, discreet, disproportionately, dissertation, distributor, distributorship, doctoral, dropped, DTD, earliest, earned, East, eliminated, enable, epidemic, eventually, exclusively, exclusivity, explain, explained, eye, Failure, faster, Feb, fibrotic, field, footnote, gateway, genital, geographic, GJ, glucose, grantee, great, greenfield, growth, guidance, Gynecology, healing, healthy, heart, heretofore, hub, hypoglycemic, Idiopathic, imitate, immunotherapy, incidence, innovative, insulin, Insurica, intestinal, intravenously, IPF, key, kidney, Laparoscopy, Lawrence, leading, lessee, lessening, Liaison, lifestyle, lifetime, Lin, liver, Living, lung, microvascular, Min, momentum, MYTREX, Nangang, nephropathy, nerve, neuropathy, Nonemployee, nonqualified, obese, obesity, obsolete, official, opposed, outpacing, overweight, pain, partial, partner, partnership, people, Pepperdine, phase, plastic, play, poor, population, prevalence, prevalent, principle, proactively, procure, procurement, Procuring, progressive, proportional, prove, Pulmonary, pulsatile, pump, ratification, ready, reclassification, relationship, remuneration, renewal, Republic, requested, residual, retinopathy, ROC, role, route, safer, scope, secondary, Sheng, show, Spidel, strong, subordinated, surgery, surgical, susceptible, Taiwanese, Task, tissue, TissueAid, TissueAidTM, topping, transplant, trend, trillion, turn, typical, undesirable, unrecognized, Update, upward, variable, VIE, virtue, Volatility, wasted, weaker, week, wound, wrote
Removed:
activate, AMAR, assessing, attractive, Braudt, Brianne, Bulletin, CAA, claim, decrease, deficit, demand, DFB, diversify, dividing, edge, employ, enterprise, expect, expired, fibromyalgia, finder, incorporate, incur, individual, instituting, investigated, leaving, length, main, maintained, markdown, markup, monthly, narrow, November, owed, Paul, payout, penny, realign, recombinant, reduced, reflect, rented, repeating, represent, retail, revitalization, security, stimulation, suitable, symbol, team, ultimately, uncollectability, unpaid, weighted
Filing tables
Filing exhibits
- 10-K Annual report
- 31.1 Exhibit 31.1A 12-31-2018
- 31.1 Exhibit 31.1B 12-31-2018
- 33.1 Exhibit 33.1 12-31-2018
- 99.1 Exhibit 99.1 12-31-2018
- 10.72 Exhibit 10.72 2018 Employee Stock Option Plan
- 10.73 Exhibit 10.73 2018 Officer, Directors, Employees and Consultants Nonqualified Stock Option Plan
- 10.74 Exhibit 10.74 2018 Stock Option Agreement - Nonqualified Stock Option
- 10.75 Exhibit 10.75 2018 Stock Option Agreement - Employee Plan
- Download Excel data file
- View Excel data file
AIMD similar filings
Filing view
External links
EXHIBIT 99.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Amarillo Biosciences, Inc. on Form 10-K for the period ended December 31, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.
Date: April 16, 2019 By: /s/ Stephen T. Chen
Stephen T. Chen
Chairman, Chief Executive Officer
Date: April 16, 2019 By: /s/ Stephen T. Chen
Stephen T. Chen
Chief Financial Officer